Coherus BioSciences (NASDAQ:CHRS) Downgraded by StockNews.com to Sell
Coherus BioSciences (NASDAQ:CHRS – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Friday. Several other analysts have also recently issued reports on CHRS. HC Wainwright restated a “buy” rating and issued a $7.00 target price on shares of […]
Coherus BioSciences (NASDAQ:CHRS – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Friday. Several other analysts have also recently issued reports on CHRS. HC Wainwright restated a “buy” rating and issued a $7.00 target price on shares of […]
